Palvella Therapeutics (NASDAQ:PVLA – Free Report) had its price objective lifted by Oppenheimer from $210.00 to $232.00 in a research report released on Friday,Benzinga reports. The firm currently has an outperform rating on the stock. PVLA has been the subject of a number of other reports. Truist Financial set a $207.00 price objective on shares […]

Eton Pharmaceuticals (NASDAQ:ETON – Get Free Report) had its price objective lifted by equities researchers at Canaccord Genuity Group from $68.00 to $80.00 in a research note issued on Friday, Benzinga reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group‘s target price points to a potential upside of 39.49% from […]

Duolingo (NASDAQ:DUOL – Get Free Report) had its target price boosted by equities research analysts at Scotiabank from $120.00 to $140.00 in a report released on Wednesday, Benzinga reports. The brokerage presently has a “sector perform” rating on the stock. Scotiabank‘s price objective points to a potential downside of 13.12% from the stock’s previous close. […]

Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) had its target price increased by investment analysts at UBS Group from $39.00 to $42.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. UBS Group‘s price target would indicate a potential upside […]

Addus HomeCare (NASDAQ:ADUS – Get Free Report) had its price target upped by analysts at Barclays from $96.00 to $101.00 in a report released on Wednesday, Benzinga reports. The firm currently has an “underweight” rating on the stock. Barclays‘s price target would indicate a potential downside of 19.95% from the stock’s current price. A number […]

AvePoint (NASDAQ:AVPT – Get Free Report) had its target price hoisted by stock analysts at TD Cowen from $15.00 to $18.00 in a research report issued on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. TD Cowen‘s target price would indicate a potential upside of 9.39% from the company’s current […]

SiTime (NASDAQ:SITM – Get Free Report) had its price objective boosted by research analysts at Rosenblatt Securities from $750.00 to $900.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Rosenblatt Securities‘s price target suggests a potential upside of 115.36% from the stock’s previous […]

DexCom (NASDAQ:DXCM – Free Report) had its target price upped by Canaccord Genuity Group from $90.00 to $97.00 in a research report released on Friday,Benzinga reports. The firm currently has a buy rating on the medical device company’s stock. DXCM has been the topic of a number of other reports. Barclays increased their target price […]

Frontier Group (NASDAQ:ULCC – Free Report) had its price target boosted by UBS Group from $6.00 to $7.00 in a report published on Friday,Benzinga reports. They currently have a neutral rating on the stock. A number of other research analysts have also recently weighed in on ULCC. Susquehanna lifted their price target on shares of […]